Showing pharmacokinetics for Urolithin A metabolite after consumption of Pomegranate, extract in mice Metabolism
Seeram N.P., Aronson W.J., Zhang Y., Henning S.M., Moro A., Lee R.P., Sartippour M., Harris D.M., Rettig M., Suchard M.A., Pantuck A.J., Belldegrun A., Heber D. (2007) Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem 55:7732-7 PubMed (17722872)
Plasma analysed without enzymatic deconjugation
| Plasma Concentration (ng/mL) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Number | Dose | Multiple Dose Duration | Time (hours) |
Polyphenol Source Name as described in publication |
|||||
| 0 | 0.5 | 1 | 2 | 4 | 6 | ||||
| 1 | 0.3 mg | Single Dose | 0 | 50 | 50 | 75 | 60 | 50 |
urolithin A
|